Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB)

CUSIP: 034569103

Q1 2025 13F Holders as of 31 Mar 2025

Holder snapshot 6 signals
Share change
+47,895
SEC-reported price per share
$1.30
Number of holders
18
Value change
+$39,506
Number of buys
9
Number of sells
5
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
41,587,315

Security key

034569103

Report period

Q1 2025

Institutions

18

Top holders

10

Ownership snapshot

Top reported holders of ANEB - Anebulo Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Aron R. English
Disclosed value leader
22NW, LP
Comparable rows
15/15
Latest evidence
24 Feb 2025
13D/G 13F Lead comparable stake: 51% 13D/G row: Aron R. English Showing 1-6 of 15 holder rows.

Quick read

Aron R. English leads the comparable SEC ownership view at 51%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Aron R. English's linked filing trail.
Comparable ownership Top 5
Aron R. English 51%
MANGROVE PARTNERS IM, LLC 6.2%
22NW, LP 37%
Nantahala Capital Management, LLC 7.3%
LVW Advisors, LLC 1.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Aron R. English
13D/G
51%
$25,877,258
21,929,880 shares
$0 24 Feb 2025
MANGROVE PARTNERS IM, LLC
13F 13D/G
Company
6.2%
from 13D/G
$3,635,757
2,525,252 shares
31 Dec 2024
22NW, LP
13F
Company
13F
37%
$25,985,064
15,467,300 shares
31 Dec 2024
Nantahala Capital Management, LLC
13F
Company
13F
7.3%
$5,101,026
3,036,325 shares
31 Dec 2024
LVW Advisors, LLC
13F
Company
13F
1.5%
$1,062,627
632,516 shares
31 Dec 2024
MORGAN STANLEY
13F
Company
13F
1%
$705,590
419,994 shares
31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
18
Shares
22,618,242
Rows available
18
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
15
Q1 2025 holders
18
Holder diff
3
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .